Allergan Shareholder Withdraws Suit Over Spurned Valeant Bid
The plaintiff suing Allergan Inc.'s board of directors for failing to properly consider Valeant Pharmaceuticals International Inc.'s takeover bid on Wednesday decided to voluntarily dismiss the derivative class action, citing Valeant's...To view the full article, register now.
Already a subscriber? Click here to view full article